“Risperidone versus quetiapine: risk of developing metabolic syndromes in patients suffering from psychiatry disorders of a health care center” (2020) Asian Journal of Pharmaceutical and Health Sciences, 10(3), pp. 2309–2317. doi:10.5530/1a3vgq24.